VISION Supported Xeris Pharmaceuticals in Diabetes Drug Research

Austin, Texas – Xeris Pharmaceuticals recently announced the completion of its Series B stock offering which will allow the commercialization of their newest Diabetes Injectable Drug offerings. The funding will be used to promote their G-Pen (a glucagon injectable)....

Introducing VISION™ 9

AUSTIN, TX – December 15, 2016 – Prelude Dynamics announces its release of VISION™ 9. VISION™ is Prelude’s Clinical Trial Optimization Platform that goes beyond EDC. The launch of VISION™ 9 has generated much excitement. It’s new features...

Customization Enrollment Graphs And Tables

  Challenge   Clients challenged Prelude Dynamics to develop customizable enrollment graphs and tables in order to quickly reflect current enrollment rates and/or adjusted projected enrollment at any point, per site or across the whole study.  In evaluating this...

Reducing Qualitative Data Analysis Through Autocomplete Text Fields

Background One of the difficulties in doing research that occurs during the data analysis phase is how to analyze open text entries. Anytime data is collected into a text field, it becomes a qualitative data point when it comes to data analysis. Analyzing qualitative...
Page 4 of 8« First...23456...Last »